ARCHIVES

Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA.

This article is from The Cancer Letter archive.

Vol. 34 No. 19 | May 16, 2008

Download PDF Visit The Full Archive

Related Articles

Letter: No Intent To Link Flags With NSABP Inquiry, ORI’s Bivens Writes

March 10, 1995

Rituximab After CVP Improves Progression-Free Survival

March 27, 2009

NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial.

April 20, 2007

Risk of Lymphoma Increases with Hepatitis C Virus Infection

May 25, 2007

In Brief: Schilsky Named ASCO Chief Medical Officer

November 1, 2012

DCCP Recompetitions Approved Board Asks Others At NIH To Help Pay For Some Resources

October 24, 1980